Back to Archived Journals » Oncolytic Virotherapy » Volume 4
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor–resistant multiple myeloma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,696 | Dovepress* | 8,348+ | 1,294 | 9,642 | |
PubMed Central* | 348 | 102 | 450 | ||
Totals | 8,696 | 1,396 | 10,092 | ||
*Since 13 January 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar